Fred Hutchinson Cancer Center
This clinical trial studies the feasibility, acceptability, appropriateness, and effectiveness of a remote screening and navigation program in increasing clinical trial enrollment among patients with prostate and bladder cancer receiving cancer care in the community setting. Genitourinary (GU) cancers, including prostate and bladder cancer, are among the most common affecting patients in the United States. In spite of recent advances, there are still only a few broad categories of treatments effective in both prostate and bladder cancer, and investigating new therapies in clinical trials is essential. In Washington State, the majority of patients with prostate and bladder cancer are treated at local community oncology sites. Patients are referred to Fred Hutch (FH) GU oncologists for clinical trials, but often this referral occurs once a patient has exhausted all standard of care options for treatment. This remote screening and navigation study involves approaching patients at community oncology and urology clinics in the Washington State area and pre-screening them for eligibility in open clinical trials at FH. Interested eligible patients will then be referred to our patient navigation program to be seen by a GU medical oncologist at Fred Hutch Cancer Center. This program may help increase access to clinical trials for patients with prostate and bladder cancer, as well as strengthen collaboration between community oncology providers and GU oncology specialists at FH.
OUTLINE: Patients have their medical records reviewed by the research nursing team and are pre-screened for open clinical trials at Fred Hutch Cancer Center. Patients NOT eligible for a clinical trial are assigned to Group I. Patients who are immediately eligible for a clinical trial are assigned to Group II. Patients who are eligible for a clinical trial in the future upon disease progression or change in status are assigned to Group III. GROUP I: Patients are notified and receive no further contact. GROUP II: Patients who are interested in learning more about the clinical trial(s) are con…
Inclusion Criteria: * Age ≥ 18 * Ability to understand English or Spanish * Records must be available to review on Epic CareEverywhere * Ability to understand and willingness to sign a written informed consent document. Legally authorized representatives (LAR) may sign and give informed consent on behalf of study participants * For participants utilizing LAR, participant must assent or otherwise be capable of completing patient-reported surveys * Receiving care for prostate or bladder cancer at participating community sites * Eastern Cooperative Oncology Group (ECOG) performance status (PS…
Undergo medical record review
Attend appointment with GU medical oncologist
Undergo clinical trial eligibility pre-screening
Undergo re-screening
Ancillary studies